These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 18334600)
1. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600 [TBL] [Abstract][Full Text] [Related]
2. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651 [TBL] [Abstract][Full Text] [Related]
4. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells. Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915 [TBL] [Abstract][Full Text] [Related]
5. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives. Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178 [TBL] [Abstract][Full Text] [Related]
6. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055 [TBL] [Abstract][Full Text] [Related]
7. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study. Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433 [TBL] [Abstract][Full Text] [Related]
9. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation. Callan HE; Jenkins RE; Maggs JL; Lavergne SN; Clarke SE; Naisbitt DJ; Park BK Chem Res Toxicol; 2009 May; 22(5):937-48. PubMed ID: 19358516 [TBL] [Abstract][Full Text] [Related]
10. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439 [TBL] [Abstract][Full Text] [Related]
11. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. Gill HJ; Hough SJ; Naisbitt DJ; Maggs JL; Kitteringham NR; Pirmohamed M; Park BK J Pharmacol Exp Ther; 1997 Aug; 282(2):795-801. PubMed ID: 9262343 [TBL] [Abstract][Full Text] [Related]
12. Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo. Tailor A; Waddington JC; Hamlett J; Maggs J; Kafu L; Farrell J; Dear GJ; Whitaker P; Naisbitt DJ; Park K; Meng X Chem Res Toxicol; 2019 Oct; 32(10):2095-2106. PubMed ID: 31468968 [TBL] [Abstract][Full Text] [Related]
13. A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals. Engler OB; Strasser I; Naisbitt DJ; Cerny A; Pichler WJ Toxicology; 2004 Apr; 197(1):47-56. PubMed ID: 15003333 [TBL] [Abstract][Full Text] [Related]
14. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine. Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587 [TBL] [Abstract][Full Text] [Related]
15. Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulphonamide hypersensitivity: a naturally occurring model of idiosyncratic drug toxicity. Lavergne SN; Danhof RS; Volkman EM; Trepanier LA Clin Exp Allergy; 2006 Jul; 36(7):907-15. PubMed ID: 16839406 [TBL] [Abstract][Full Text] [Related]
16. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Naisbitt DJ; Gordon SF; Pirmohamed M; Burkhart C; Cribb AE; Pichler WJ; Park BK Br J Pharmacol; 2001 May; 133(2):295-305. PubMed ID: 11350866 [TBL] [Abstract][Full Text] [Related]
17. Drug metabolite-specific lymphocyte responses in sulfamethoxazole allergic patients with cystic fibrosis. Lavergne SN; Whitaker P; Peckham D; Conway S; Park BK; Naisbitt DJ Chem Res Toxicol; 2010 Jun; 23(6):1009-11. PubMed ID: 20481640 [TBL] [Abstract][Full Text] [Related]
18. Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole. Gruchalla RS; Pesenko RD; Do TT; Skiest DJ J Allergy Clin Immunol; 1998 Mar; 101(3):371-8. PubMed ID: 9525454 [TBL] [Abstract][Full Text] [Related]
19. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso. Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451 [TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine. Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]